COVID-19 se asocia a un mayor riesgo de desarrollar el síndrome de Guillain-Barré, un trastorno autoinmune raro pero grave, según un nuevo estudio
Related Posts
First Shots Given in Trial of Moderna’s mRNA-Based HIV Vaccine
February 1, 2022
TUESDAY, Feb. 1, 2022 (HealthDay News) -- Vaccinations have been given to the...
Surgeon Volume Impacts Outcomes After Shoulder Replacement
June 23, 2023
FRIDAY, June 23, 2023 (HealthDay News) -- The risk for adverse patient outcomes...
Parental Leave Does Not Impact Residents’ Subsequent Board Scores
July 27, 2022
WEDNESDAY, July 27, 2022 (HealthDay News) -- Taking extended leave during...
AHA News: Lower Income Linked to Higher Odds of Clogged Neck Arteries
February 9, 2022
WEDNESDAY, Feb. 9, 2022 (American Heart Association News) -- People making less...